1Fujii H, Kono K, Nakai K ,et al. Oxidative and nitrosarive stress and progression of diabetic nephropathy in type 2 diabetes[J]. Am J Nephrol, 2010, 31 (4) : 342 -352.
3Calle R, Mc Carthy M I, Banerjce P, et al. Paraoxonase2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76 [ J ]. Diabetologia, 2006 , 49(12): 2892-2899.
4Hodgkinson A D,Millward B, Pinizzotto M, et al. Para- oxonase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes [ J]. Diabetologia, 2002, 45(6) :104 - 107.
5ShinB S, O h S Y, Kim Y S, et al. The paraoxonase gene polymorphism in stroke patients and lipid profile [J]. Acta Neurol Scand,2008 , 117(4) : 237 -243.
6Bharti M, Paul N. Low paraoxonase activity in type Ⅱ di- abetes mellitus complicated by retinopathy [ J ]. Clinical Science,2000,98(3) :355 - 363.
7Murata M,Maruyama T. Paraoxonase 1 192Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus [ J]. Diabetic Medicine, 2004,21 ( 8 ) : 837 - 844.
